Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec 15;131(12):2929-38.
doi: 10.1002/ijc.27571. Epub 2012 Apr 24.

Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies

Affiliations

Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies

Fang-Hui Zhao et al. Int J Cancer. .

Abstract

High-risk (HR) human papillomavirus (HPV) prevalence has been shown to correlate well with cervical cancer incidence rates. Our study aimed to estimate the prevalence of HR-HPV and cervical intraepithelial neoplasia (CIN) in China and indirectly informs on the cervical cancer burden in the country. A total of 30,207 women from 17 population-based studies throughout China were included. All women received HPV DNA testing (HC2, Qiagen, Gaithersburg, MD), visual inspection with acetic acid and liquid-based cytology. Women positive for any test received colposcopy-directed or four-quadrant biopsies. A total of 29,579 women had HR-HPV testing results, of whom 28,761 had biopsy confirmed (9,019, 31.4%) or assumed (19,742, 68.6%) final diagnosis. Overall crude HR-HPV prevalence was 17.7%. HR-HPV prevalence was similar in rural and urban areas but showed dips in different age groups: at age 25-29 (11.3%) in rural and at age 35-39 (11.3%) in urban women. In rural and urban women, age-standardized CIN2 prevalence was 1.5% [95% confidence interval (CI): 1.4-1.6%] and 0.7% (95% CI: 0.7-0.8%) and CIN3+ prevalence was 1.2% (95% CI: 1.2-1.3%) and 0.6% (95% CI: 0.5-0.7%), respectively. Prevalence of CIN3+ as a percentage of either all women or HR-HPV-positive women steadily increased with age, peaking in 45- to 49-year-old women. High prevalence of HR-HPV and CIN3+ was detected in both rural and urban China. The steady rise of CIN3+ up to the age group of 45-49 is attributable to lack of lesion removal through screening. Our findings document the inadequacy of current screening in China while indirectly raising the possibility that the cervical cancer burden in China is underreported.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart of inclusion and exclusion criteria of the study sample
Figure 2
Figure 2
Prevalence of high-risk HPV DNA stratified by residence
Figure 3
Figure 3
Prevalence of CIN1, CIN2 and CIN3+ stratified by age group among rural women
Figure 4
Figure 4
Prevalence of CIN1, CIN2 and CIN3+ in rural women with high-risk HPV stratified by age group

References

    1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917. - PubMed
    1. International Agency for Research on Cancer (IARC) W. IARC Handbooks of Cancer Prevention: Cervix Cancer Screening. Lyon: IARC Press; 2005. Chapter 2.
    1. Curado MP, Edwards B, Shin HR, Storm H, Frelay J, Heanue M, Boyle P. Cancer incidence in five continents. Vol IX. Lyon, IARC: IARC Scientific Publications No. 160; 2007.
    1. Shi JF, Canfell K, Lew JB, Qiao YL. The burden of cervical cancer in China: synthesis of the evidence. Int J Cancer. 2012;130(3):641–652. - PubMed
    1. Xie FZ. Beijing: China Statistics Press; 2008. [accessed on 20-2-2010]. China Statistical Yearbook – 2008. Available at http://www.stats.gov.cn/tjsj/ndsj/2008/indexch.htm.

Publication types